MTOR and breast cancer: Inhibition or genetic deletion of mTOR or S6K1 in mouse embryonic fibroblasts or breast cancer, but also in murine diabetes models resulted in Ras-MAPK activation via insulin receptor substrate-1 (IRS) [17], [18].